Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshimi Arima

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Cancer Science|March 3, 2018
Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanomaTakashi Semba, Eiji Sugihara, Nagisa Kamoshita, et al.
International Journal of Molecular Sciences|July 26, 2018
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast CancerMari Hosonaga, Yoshimi Arima, Oltea Sampetrean, et al.
The Journal of Biological Chemistry|January 21, 2012
Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancerYoshimi Arima, Hidemi Hayashi, Mikako Sasaki, et al.
Oncogene|July 12, 2005
The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell deathShinji Kuninaka, Masanobu Nomura, Toru Hirota, et al.
Scientific Reports|April 19, 2018
Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cellsRitsuko Harigai, Shigeki Sakai, Hiroyuki Nobusue, et al.
The Journal of Cell Biology|May 30, 2012
LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progressionTatsuyuki Chiyoda, Naoyuki Sugiyama, Takatsune Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant gliomaNaoki Yajima, Ryuya Yamanaka, Takashi Mine, et al.
Scientific Reports|April 15, 2016
Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblastsKazuhiro Umeyama, Kota Watanabe, Masahito Watanabe, et al.
Genetic Testing and Molecular Biomarkers|October 18, 2014
The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation studyRyo Maruoka, Toshiki Takenouchi, Chiharu Torii, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Science|March 3, 2018
Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanomaTakashi Semba, Eiji Sugihara, Nagisa Kamoshita, et al.
International Journal of Molecular Sciences|July 26, 2018
HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast CancerMari Hosonaga, Yoshimi Arima, Oltea Sampetrean, et al.
The Journal of Biological Chemistry|January 21, 2012
Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancerYoshimi Arima, Hidemi Hayashi, Mikako Sasaki, et al.
Oncogene|July 12, 2005
The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell deathShinji Kuninaka, Masanobu Nomura, Toru Hirota, et al.
Scientific Reports|April 19, 2018
Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cellsRitsuko Harigai, Shigeki Sakai, Hiroyuki Nobusue, et al.
The Journal of Cell Biology|May 30, 2012
LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progressionTatsuyuki Chiyoda, Naoyuki Sugiyama, Takatsune Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant gliomaNaoki Yajima, Ryuya Yamanaka, Takashi Mine, et al.
Scientific Reports|April 15, 2016
Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblastsKazuhiro Umeyama, Kota Watanabe, Masahito Watanabe, et al.
Genetic Testing and Molecular Biomarkers|October 18, 2014
The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation studyRyo Maruoka, Toshiki Takenouchi, Chiharu Torii, et al.
Pageof 4